Company performance
Add to research
Current Price
as of Feb 07, 2025$11.92
P/E Ratio
N/A
Market Cap
$1.16B
Description
Add to research
ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.
Metrics
Add to research
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerSBTX
- Price$11.92-6.88%
Trading Information
- Market cap$1.16B
- Float51.96%
- Average Daily Volume (1m)1,412,506
- Average Daily Volume (3m)1,353,180
- EPS-$0.51
Company
- Revenue$2.57M
- Rev growth (1yr)N/A
- Net income-$19.13M
- Gross margin93.57%
- EBITDA margin-1,050.63%
- EBITDA-$21.73M
- EV$1.20B
- EV/Revenue468.24
- P/EN/A
- P/S450.40
- P/B5.76
- Debt/Equity0.05
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls